These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2719010)

  • 1. Occurrence of immunohistochemically detected small Mallory bodies in liver disease.
    Yoshioka K; Kakumu S; Tahara H; Arao M; Fuji A; Hirofuji H; Hayashi T; Kano H
    Am J Gastroenterol; 1989 May; 84(5):535-9. PubMed ID: 2719010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin: an immunohistochemical marker of Mallory bodies and alcoholic liver disease.
    Vyberg M; Leth P
    APMIS Suppl; 1991; 23():46-52. PubMed ID: 1652996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a specific monoclonal antibody to detect Mallory bodies in liver disease.
    Leevy CB; Sameshima Y; Yoshioka K; Leevy CM; Kanagasundaram N; Unoura M
    J Assoc Acad Minor Phys; 1990; 1(2):24-5, 28-30. PubMed ID: 2135694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study on Mallory bodies. Isolation, ultrastructure and preliminary biochemical characterization of Mallory bodies from livers of alcoholic cirrhosis and malignant hepatoma.
    Okamura K
    Acta Pathol Jpn; 1976 Nov; 26(6):649-70. PubMed ID: 189565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcoholic liver disease: molecular-pathologic aspects.
    Zatloukal K; Kenner L; Preisegger KH; Denk H
    Verh Dtsch Ges Pathol; 1995; 79():28-35. PubMed ID: 8600692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of Mallory bodies in Wilsonian and non-Wilsonian hepatic copper toxicosis.
    Müller T; Langner C; Fuchsbichler A; Heinz-Erian P; Ellemunter H; Schlenck B; Bavdekar AR; Pradhan AM; Pandit A; Müller-Höcker J; Melter M; Kobayashi K; Nagasaka H; Kikuta H; Müller W; Tanner MS; Sternlieb I; Zatloukal K; Denk H
    Hepatology; 2004 Apr; 39(4):963-9. PubMed ID: 15057900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mallory bodies: isolation of hepatocellular hyalin and electrophoretic resolution of polypeptide components.
    Tinberg HM; Regan RJ; Geier EA; Peterson GE; French SW
    Lab Invest; 1978 Nov; 39(5):483-90. PubMed ID: 83449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High molecular weight component of Mallory bodies detected by a monoclonal antibody.
    Zatloukal K; Denk H; Spurej G; Lackinger E; Preisegger KH; Franke WW
    Lab Invest; 1990 Apr; 62(4):427-34. PubMed ID: 1692099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo expression of nonhepatocellular cytokeratins in Mallory body formation.
    Schirmacher P; Dienes HP; Moll R
    Virchows Arch; 1998 Feb; 432(2):143-52. PubMed ID: 9504859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetaldehyde-modified epitopes in liver biopsy specimens of alcoholic and nonalcoholic patients: localization and association with progression of liver fibrosis.
    Holstege A; Bedossa P; Poynard T; Kollinger M; Chaput JC; Houglum K; Chojkier M
    Hepatology; 1994 Feb; 19(2):367-74. PubMed ID: 7507463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxidase-antiperoxidase complex. Binding by Mallory bodies in unfixed tissue.
    Sim JS; French SW
    Arch Pathol Lab Med; 1976 Oct; 100(10):550-3. PubMed ID: 989279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental Mallory body formation is accompanied by modulation of the expression of multidrug-resistance genes and their products.
    Preisegger KH; Stumptner C; Riegelnegg D; Brown PC; Silverman JA; Thorgeirsson SS; Denk H
    Hepatology; 1996 Jul; 24(1):248-52. PubMed ID: 8707270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Variability of the clinical and laboratory aspects in the presentation of chronic liver diseases in relation to their etiology. Analysis of a case study and review of the literature].
    Cozzolino G; Francica G; Lonardo A; Cerini R; Cacciatore L
    Minerva Med; 1985 Apr; 76(16):753-60. PubMed ID: 2582312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mallory bodies. Horseradish peroxidase: specific cytochemical and biochemical marker for alcoholic hyalin.
    Tinberg HM; Geier EA; Beirne J; Burbige E; French SW
    Lab Invest; 1979 Jul; 41(1):13-21. PubMed ID: 87542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Mallory body: theories on development and pathological significance (Part 2 of a literature survey).
    Jensen K; Gluud C
    Hepatology; 1994 Nov; 20(5):1330-42. PubMed ID: 7927269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disorganisation of intermediate filament structure in alcoholic and other liver diseases.
    Barbatis C; Morton J; Woods JC; Burns J; Bradley J; McGee JO
    Gut; 1986 Jul; 27(7):765-70. PubMed ID: 3732887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical profiles of Mallory body by a panel of anti-cytokeratin antibodies.
    Pei RJ; Danbara N; Tsujita-Kyutoku M; Yuri T; Tsubura A
    Med Electron Microsc; 2004 Jun; 37(2):114-8. PubMed ID: 15221653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should patients with type 2 diabetes and raised liver enzymes be referred for further evaluation of liver disease?
    Hickman IJ; Russell AJ; Prins JB; Macdonald GA
    Diabetes Res Clin Pract; 2008 Apr; 80(1):e10-2. PubMed ID: 18187226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease. Correlation with histology and viral hepatitis.
    Akyol G; Erdem O; Yilmaz G
    Saudi Med J; 2005 Dec; 26(12):1904-10. PubMed ID: 16380770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte sequestration by the liver in alcoholic hepatitis.
    French SW; Burbige EJ; Tarder G; Bourke E; Harkin CG; Denton T
    Arch Pathol Lab Med; 1979 Mar; 103(3):146-52. PubMed ID: 311627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.